# Author Correction: Concurrent intrathecal and intravenous nivolumab in leptomeningeal disease: phase 1 trial interim results

**Authors:** Isabella C. Glitza Oliva, Sherise D. Ferguson, Roland Bassett, Alexandra P. Foster, Ida John, Tarin D. Hennegan, Michelle Rohlfs, Jessie Richard, Masood Iqbal, Tina Dett, Carol Lacey, Natalie Jackson, Theresa Rodgers, Suzanne Phillips, Sheila Duncan, Lauren Haydu, Ruitao Lin, Rodabe N. Amaria, Michael K. Wong, Adi Diab, Cassian Yee, Sapna P. Patel, Jennifer L. McQuade, Grant M. Fischer, Ian E. McCutcheon, Barbara J. O’Brien, Sudhakar Tummala, Matthew Debnam, Nandita Guha-Thakurta, Jennifer A. Wargo, Fernando C. L. Carapeto, Courtney W. Hudgens, Jason T. Huse, Michael T. Tetzlaff, Elizabeth M. Burton, Hussein A. Tawbi, Michael A. Davies

PMC · DOI: 10.1038/s41591-024-02998-5 · 2024-04-22

## Full-text entities

- **Diseases:** leptomeningeal disease (MESH:D008577)

---
Source: https://tomesphere.com/paper/PMC11186776